Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

News

      Samsung Biologics Acquires GSK’s Human Genome Sciences Site in U.S.

      Americas
      Samsung Biologics has agreed to acquire 100% of Human Genome Sciences from GSK, a move that secures the company’s first U.S.-based biologics manufacturing site...

      Cytokinetics Secures First FDA Approval With Myqorzo Heart Drug

      Drug Development
      Cytokinetics has reached a defining milestone after the U.S. Food and Drug Administration approved its heart drug Myqorzo for adults with obstructive hypertrophic cardiomyopathy,...

      Thermo Fisher launches Alzheimers Disease Registry

      Clinical Trials
      Thermo Fisher Scientific Inc., which is regarded as the world leader when it comes to serving science, went on to announce the enrollment of...

      Meiji Seika Pharma, MBC BioLabs Drug Discovery Partnership

      Drug Development
      Meiji Seika Pharma has entered into a strategic collaboration with MBC BioLabs to deepen its global drug discovery innovation partnership and strengthen external research...

      Astellas Pharma, Autobahn Labs Partnership Strengthens R&D

      Drug Development
      Astellas Pharma has entered a strategic partnership with Autobahn Labs to accelerate the translation of academic research into novel drug discovery and development programs,...

      Zealand Pharma, OTR Therapeutics Sign Collaboration Deal

      Drug Development
      Zealand Pharma, OTR Therapeutics sign collaboration through a strategic collaboration and license agreement to discover and develop new therapies for metabolic diseases. The deal...

      FDA Approves Inebilizumab-cdon for gMG Treatment in Adults

      Americas
      The U.S. Food and Drug Administration (FDA) has approved inebilizumab-cdon (Uplizna; Amgen) for the treatment of adults with generalized myasthenia gravis who are anti-acetylcholine...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector .....Read More

      System

      Resources

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.